Advertisement
Review Article| Volume 38, ISSUE 1, P21-35, March 2018

Global Health Pathology Research

Purpose and Funding
Published:December 22, 2017DOI:https://doi.org/10.1016/j.cll.2017.10.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. NCI Center for Global Health (CGH). National Cancer Institute. 2017. Available at: https://www.cancer.gov/about-nci/organization/cgh. Accessed June 13, 2017.

      2. Comprehensive cancer information. National Cancer Institute. 2017. Available at: https://www.cancer.gov/. Accessed June 13, 2017.

      3. National Institutes of Health (NIH). National Institutes of Health (NIH). 2017. Available at: https://www.nih.gov/. Accessed June 13, 2017.

        • Varmus H.
        • Trimble E.L.
        Integrating cancer control into global health.
        Sci Transl Med. 2011; 3: 101cm128
        • Mmbaga E.J.
        • Deardorff K.V.
        • Mushi B.
        • et al.
        Characteristics of esophageal cancer cases in Tanzania.
        Journal of Global Oncology. 2017; ([Epub ahead of print])
      4. PAR-16-279: Fogarty HIV research training program for low-and middle-income country institutions (D43). National Institute of Health grants. 2017. Available at: https://grants.nih.gov/grants/guide/pa-files/PAR-16-279.html. Accessed June 13, 2017.

      5. RFA-CA-15-1007: planning for regional centers of research excellence in non-communicable diseases in low and middle income countries (P20). National Institute of Health grants. 2017. Available at: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-007.html. Accessed June 13, 2017.

      6. PAR-15-093: basic cancer research in cancer health disparities (R01). National Institute of Health grants. 2017. Available at: https://grants.nih.gov/grants/guide/pa-files/PAR-15-093.html. Accessed June 13, 2017.

      7. RFA-CA-15-1001: cancer detection, diagnosis, and treatment technologies for global health (UH2/UH3). National Institute of Health grants. 2017. Available at: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-001.html. Accessed June 13, 2017.

      8. PAR-16-238: dissemination and implementation research in health (R01). National Institute of Health grants. 2017. Available at: https://grants.nih.gov/grants/guide/pa-files/PAR-16-238.html. Accessed June 13, 2017.

      9. Fogarty International Center. Fogarty International Center. 2017. Available at: http://www.fic.nih.gov. Accessed June 13, 2017.

        • MacLeod S.M.
        • Knoppert D.C.
        • Stanton-Jean M.
        • et al.
        Pediatric clinical drug trials in low-income countries: key ethical issues.
        Paediatr Drugs. 2015; 17: 83-90
      10. NCI grant activity codes/mechanisms. National Cancer Institute: Division of Extramural Affairs. 2017. Available at: https://deainfo.nci.nih.gov/flash/awards.htm#R01. Accessed June 13, 2017.

      11. Laboratory of pathology | Center for Cancer Research. National Cancer Institute: Center for Cancer Research. 2017. Available at: https://ccr.cancer.gov/Laboratory-of-Pathology. Accessed June 13, 2017.

        • Koplan J.P.
        • Baggett R.L.
        The Emory Global Health Institute: developing partnerships to improve health through research, training, and service.
        Acad Med. 2008; 83: 128-133
        • Dean L.
        • Njelesani J.
        • Smith H.
        • et al.
        Promoting sustainable research partnerships: a mixed-method evaluation of a United Kingdom–Africa capacity strengthening award scheme.
        Health Res Policy Syst. 2015; 13: 81
      12. Center for Translation Research and Implementation Science (CTRIS) - NHLBI, NIH. National Heart, Lung, and Blood Institute. 2017. Available at: http://www.nhlbi.nih.gov/about/org/ctris. Accessed June 13, 2017.

      13. RFA-HL-17-1003: T4 Translation research capacity building initiative in low income countries (TREIN) (U24). National Institute of Health Grants. 2017. Available at: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-003.html. Accessed June 13, 2017.

      14. PAR-17-095: Cancer Center Support Grants (CCSGs) for NCI-designated cancer centers (P30). National Institute of Health Grants. 2017. Available at: https://grants.nih.gov/grants/guide/pa-files/PAR-17-095.html. Accessed June 13, 2017.

      15. Muir JA, Farley J, Osterman A, et al. Global health programs and partnerships: evidence of mutual benefit and equity. A report of the CSIS Global Health Policy Center. 2016. Available at: https://csis-prod.s3.amazonaws.com/s3fs-public/publication/160315_Muir_GlobalHealthPrograms_Web.pdf. Accessed June 6, 2017.

        • Hopkins J.
        • Burns E.
        • Eden T.
        International twinning partnerships: an effective method of improving diagnosis, treatment and care for children with cancer in low-middle income countries..
        J Cancer Policy. 2013; 1: e8-e19
      16. Global health program for fellows and scholars - Fogarty International Center @ NIH. Fogarty International Center. 2017. Available at: https://www.fic.nih.gov/Programs/pages/scholars-fellows-global-health.aspx. Accessed June 13, 2017.

        • Asombang A.W.
        • Kayamba V.
        • Mwanza-Lisulo M.
        • et al.
        Gastric cancer in Zambian adults: a prospective case-control study that assessed dietary intake and antioxidant status by using urinary isoprostane excretion.
        Am J Clin Nutr. 2013; 97: 1029-1035
        • Montgomery N.D.
        • Liomba N.G.
        • Kampani C.
        • et al.
        Accurate real-time diagnosis of lymphoproliferative disorders in Malawi through clinicopathologic teleconferences a model for pathology services in sub-Saharan Africa.
        Am J Clin Pathol. 2016; 146: 423-430
        • Fleming K.A.
        • Naidoo M.
        • Wilson M.
        • et al.
        An essential pathology package for low- and middle-income countries.
        Am J Clin Pathol. 2017; 147: 15-32
      17. WHO list of priority medical devices for cancer management. World Health Organization, Geneva (Switzerland)2017 (Licence: CC BY-NC-SA 3.0 IGO)
        • Ellis D.W.
        • Srigley J.
        Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based datasets.
        Virchows Arch. 2016; 468: 51-59
        • Global Burden of Disease Cancer Collaboration
        Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study.
        JAMA Oncol. 2017; 3: 524-548
      18. First cohort of ACTs enters second phase. National Cancer Institute. 2017. Available at: https://www.cancer.gov/about-nci/organization/cgh/blog/2017/acts-transition. Accessed June 14, 2017.